About Deerfield

Launched in 1994, Deerfield Management Company is an investment firm dedicated to advancing healthcare through information, investment, and philanthropy—all toward the end goal of cures for disease, improved quality of life, and reduced cost of care.

Read More

Supporting companies across the healthcare ecosystem with flexible funding models…

Read More

Delivering market research to the Deerfield team, its portfolio companies and other partners.

Read More ---

A New York City-based not-for-profit devoted to advancing innovative health care initiatives.

Read More
Research Collaborations

Deerfield partners with leading academic research centers, providing critical funding and expertise to further sustain and accelerate the commercialization of discoveries toward meaningful societal impact by advancing cures for disease.

Read More
Strategic Partners

As a strategic partner, Deerfield offers capital, scientific expertise, business operating support, and unique access to innovation.

Deerfield Foundation

The Deerfield Foundation is a New York City-based not-for-profit organization whose mission is to improve health, accelerate innovation and promote human equity.

Read More Meet the Foundation Team
Cure Campus

Cure is a 12-story innovations campus in New York City that intends to bring together innovators from academia, government, industry, and the not-for-profit sectors to advance human health and accelerate the fight against disease.

Read More Meet the Cure Team Join the Cure Email List
Cure Programming

Cure has a series of expert lectures intended to advance thought in healthcare, management, innovation, policy, and other relevant subjects. This fosters growth and education for those at Cure and its guests.

Events at the Cure

Alessandro Mora, Ph.D.

Alessandro Mora, Ph.D. is a Senior Director, Biopharmaceutical Development, Deerfield Discovery and Development, and joined the Firm in 2022. Prior to Deerfield, Dr. Mora spent two years at Kadmon, a Sanofi Company where he was Director, CMC Biologics. Before Kadmon, Dr. Mora spent three years at Jounce Therapeutics as a Principal Scientist, CMC Operations, Product Development and Technical Operations, and seven years at AbbVie / Abbott Bioresearch Center as a Scientist, Cell Line Development, Process Sciences. Dr. Mora holds a B.S and an M.Sc. in Biotechnology from Sapienza University in Rome, Italy, and a Ph.D. in Biomedical Engineering and Biotechnology from University of Massachusetts Lowell.